Nonvested Options
Option
Weighted-Average Exercise Price
Nonvested at December, 2017
1,492,861
$1.54
Granted
280,000
$1.75
Vested
(972,651)
$1.29
Forfeited
Nonvested at December, 2018
800,210
$1.63
Granted
126,567
$1.15
Vested
(584,895)
$1.46
Forfeited
(137,500)
$1.75
Nonvested at December, 2019
204,382
$1.74
a summary of the status of the company ’ s nonvested options as of december 31 2019 and changes during the year ended december 31 2019 is presented below .
as of december 31 2019 the company had 3835366 shares issuable under options outstanding at a weighted average exercise price of $ 1 .
34 and an intrinsic value of $ 635536 .
as of december 31 2019 the company had 3846299 shares issuable under options outstanding at a weighted average exercise price of $ 1 .
36 and an intrinsic value of $ 2150912 .
the total number of options granted during the year ended december 2019 and 2018 was 126567 and 280000 respectively .
the exercise price for these options was $ 1 .
00 per share $ 1 .
25 per share or $ 1 .
75 per share .
the company recognized compensation expense related to options issued of $ 797761 and $ 1130071 during the year ended december 31 2019 and 2018 respectively which is included in general and administrative expenses and research and development expenses .
for the year ended december 31 2019 $ 562734 of the stock compensation was related to employees and $ 235027 was related to non-employees .
on january 24 2018 the company entered into a consulting agreement -the “ agreement ” with neuroassets s à rl - “ consultant ” a swiss company .
as part of the agreement on february 20 2018 the compensation committee of the company ’ s board of directors approved a grant of 200000 options under our 2016 equity compensation plan .
the options vest over 48 months in equal monthly installments with the first monthly vesting event scheduled to occur on march 20 2018 have a term of ten years and are exercisable at a price of $ 1 .
75 per share .
the vesting of the options will accelerate if a corporate partnership results from an introduction made by consultant .
on january 24 2018 the company entered into a consulting agreement -the “ agreement ” with neuroassets s à rl - “ consultant ” a swiss company .
as part of the agreement on february 20 2018 the compensation committee of the company ’ s board of directors approved a grant of 200000 options under our 2016 equity compensation plan .
the options vest over 48 months in equal monthly installments with the first monthly vesting event scheduled to occur on march 20 2018 have a term of ten years and are exercisable at a price of $ 1 .
75 per share .
the vesting of the options will accelerate if a corporate partnership results from an introduction made by consultant .
during the first quarter of 2018 the company granted 80000 stock options to four consultants .
50000 of these options vest immediately and the remaining 30000 options vest monthly over 48 months have an exercise price of $ 1 .
75 and have a term of ten years .
as of december 31 2019 the unamortized stock option expense was $ 287905 with $ 144423 being related to employees and $ 143482 being related to non-employees .
as of december 31 2019 the weighted average period for the unamortized stock compensation to be recognized is 3 .
98 years .
on february 25 2019 the company granted 101567 options with an exercise price of $ 1 .
00 and a ten year term .
59900 of these options vest immediately and 41667 vest bi-weekly over two months .
these options have a black-scholes value of $ 199807 .
the company issued 59900 options for settlement of accounts payable totaling $ 29850 and recorded a loss of $ 99541 on the settlement of the accounts payable on february 25 2019 the company granted 101567 options with an exercise price of $ 1 .
00 and a ten year term .
59900 of these options vest immediately and 41667 vest bi-weekly over two months .
these options have a black-scholes value of $ 199807 .
the company issued 59900 options for settlement of accounts payable totaling $ 29850 and recorded a loss of $ 99541 on the settlement of the accounts payable .
on june 17 2019 the company granted 25000 options with an exercise price of $ 1 .
75 and a ten year term .
these options vest immediately and have a black-scholes value of $ 36374 .

Question: What is the percentage of options granted during the year ended December 2018 as a percentage of the number of nonvested options remaining as at 31 December 2018?
Answer: 34.99